United Kingdom · Series C startup

Who invested in Conjunct

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Telecoms

Funding summaryUpdated 26 Oct 2026

$935Kraised across 2 rounds since 2010, from 2 sources

$402KVenture$533KSeries C
Latest round
Series C, $533KDec 2011
Step-upi
1.3×
Investors
3
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2011
$402KVenture$533KSeries C
First round
Venture, $402K
May 2010
Biggest round
$533K
Series C · Dec 2011
Between rounds
19 months
from the last two

The rounds

  1. Dec 2011
  2. May 2010
    Venture$402K3 new

    From a historical funding record

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Scottish EnterpriseGovernment2rounds
LINC ScotlandVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Conjunct

Who invested in Conjunct?

Conjunct's investors include Scottish Enterprise, Braveheart Investment Plc and LINC Scotland.

How much has Conjunct raised?

Conjunct has raised $935K across 2 rounds since 2010.

When did Conjunct last raise?

Conjunct's most recent round was a Series C of $533K in Dec 2011.

What was Conjunct's biggest round?

Its most recent round, $533K in Dec 2011, is also its largest on record.

Who backed Conjunct first?

Conjunct's first round on record, in May 2010, was backed by Scottish Enterprise, Braveheart Investment Plc and LINC Scotland.

What stage is Conjunct at?

Conjunct's latest named round is a Series C, in Dec 2011.

Where is Conjunct based?

Conjunct is based in the United Kingdom.

Companies like Conjunct

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.